@FiercePharma: Biogen expects MS sales hit from Gilenya. Article | Follow @FiercePharma
> Some 11 drugmakers have filed suit against the Czech Republic's Health Ministry over the setting of maximum prices for their products, and as many as 20 more companies may follow suit. Story
> French drugmaker Sanofi-Aventis won European Union regulatory approval for its hostile $18.5 billion takeover bid for U.S. biotech firm Genzyme, even before a deal has been struck. News
> Watson Pharmaceuticals said its 2010 profit appears to be at or slightly above the midpoint of its latest forecast, based on a preliminary review of results. Report
> Allergan sued a unit of Switzerland's Novartis in federal court in Delaware alleging infringement of four U.S. patents for Sanctura XR, a prescription medicine used to treat overactive bladder. Report
> Sunovion Pharmaceuticals quietly mothballed a Lunesta TV ad that drew FDA scrutiny in favor of a spot that reprises the sleep drug's familiar mascot, a glowing moth. Article
> Shanghai Pharmaceuticals aims to raise at least ¥8 billion ($1.21 billion) in a Hong Kong listing before the end of June. Item
@FierceBiotech: Brain swelling reported in Lilly Alzheimer's trial. Story | Follow @FierceBiotech
@JohnCFierce: I've been hearing a lot from public biotechs about underpriced shares, to me it sounds that investors want product data/not R&D promises. Follow @JohnCFierce
> Endo chief looks to spend $500M on acquisitions. News
> AZ, Cancer Research UK to collaborate on cancer trials. Article
> Zohar: PureTech focuses on quality of technology, not quantity. Story
> FDA panel wants more data on Lilly's Solpura. Item
Vaccines News
> DOD grants pandemic flu funding. Report
> BJM: Wakefield planned to profit from vaccine scare. News
> Merck's Zostavax halves risk of shingles. Story
> Vaccine could give alcoholics 'hangovers' after one drink. Article
> British PM: We will learn from the current flu crisis. Item
Manufacturing News
> Cerezyme departs drug-shortage list; BMS injection joins. Story
> Under- and overweight generics drive recalls. Article
> J&J: No basis for Motrin-buyback lawsuit. Item
> Market forecast: Sunny skies for contract manufacturers. News
> Recycle solvents for big emissions cut. Report
> PC imaging wages war on particle contamination. Item
And Finally... Rapidly increasing diabetes rates in the Middle East and North Africa are giving rise to concerns about the costs of treatment. Report